A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 2 Fixed Dosages of Paliperidone Extended Release Tablets and Olanzapine, With Open-label Extension, in the Treatment of Patients With Schizophrenia
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004597/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this trial is to determine if paliperidone ER is an effective treatment for adults with schizophrenia.
提供机构：
Vivli
创建时间：
2019-09-19
